Amanda G. Paulovich

Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers.

A reagent resource to identify proteins and peptides of interest for the cancer community: a workshop report.

Normalization regarding non-random missing values in high-throughput mass spectrometry data.

Head-to-head comparison of serum fractionation techniques.

Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.

A human proteome detection and quantitation project.

A radiation-derived gene expression signature predicts clinical outcome for breast cancer patients.

The evolving role of mass spectrometry in cancer biomarker discovery.

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Antibody-based screen for ionizing radiation-dependent changes in the Mammalian proteome for use in biodosimetry.

Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses.

An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers.

Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance.

Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry.

Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry.

The Saccharomyces cerevisiae RAD9, RAD17 and RAD24 genes are required for suppression of mutagenic post-replicative repair during chronic DNA damage.

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry.

Blood-Based Detection of Radiation Exposure in Humans Based on Novel Phospho-Smc1 ELISA.

Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.

Blood-based detection of radiation exposure in humans based on novel phospho-Smc1 ELISA.

Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.

A targeted proteomics-based pipeline for verification of biomarkers in plasma.

Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.

Inter-laboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.

Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry.